Baxalta Loses Motion for Patent Infringement Retrial Against Bayer

A federal court in Delaware has denied Baxalta’s request for a new trial in a suit brought by Bayer over patent infringement by Baxalta’s hemophilia A drug Adynovate. 
Source: Drug Industry Daily